# DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery

> **NCT04362241** · PHASE4 · UNKNOWN · sponsor: **Ophthalmic Consultants of the Capital Region** · enrollment: 30 (estimated)

## Conditions studied

- Retinopathy, Diabetic

## Interventions

- **DRUG:** Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]

## Key facts

- **NCT ID:** NCT04362241
- **Lead sponsor:** Ophthalmic Consultants of the Capital Region
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-07
- **Primary completion:** 2022-02
- **Final completion:** 2022-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362241, "DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04362241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*